ACP
EXEL icon

Acuta Capital Partners’s Exelixis EXEL Stock Holding History

Acuta Capital Partners’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50,000
Closed -$1.52M – 72
2017
Q4 		$1.52M Buy
+50,000
New +$1.33M 0.29% 47
2015
Q2 		– Sell
-329,000
Closed -$846K – 54
2015
Q1 		$846K Buy
+329,000
New +$764K 0.71% 36

Other funds holding EXEL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Acuta Capital Partners's EXEL Position: Q2 2016 in Review

Acuta Capital Partners sold out of Exelixis (EXEL) in Q2 2016, closing a stake of 320,897 shares — an estimated $1.28M sold.

Acuta Capital Partners first reported a position in EXEL in Q3 2015 and held it in 3 quarters. The position peaked at $10.5M in Q3 2015. 166 funds tracked by Wall St. Rank hold EXEL as of Q2 2016.

  • Acuta Capital Partners reported no remaining Exelixis position as of Q2 2016 after selling out during the quarter.
  • Acuta Capital Partners sold 320,897 Exelixis shares in Q2 2016, an estimated $1.28M.
  • Acuta Capital Partners first reported a position in Exelixis in Q3 2015 and held it in 3 quarters.
  • Acuta Capital Partners's Exelixis position peaked at $10.5M in Q3 2015.
  • 166 funds tracked by Wall St. Rank held Exelixis as of Q2 2016.

Based on Acuta Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.